Insider Selling: HealthEquity, Inc. (NASDAQ:HQY) Director Sells 134,183 Shares of Stock

HealthEquity, Inc. (NASDAQ:HQY - Get Free Report) Director Jon Kessler sold 134,183 shares of the company's stock in a transaction dated Friday, June 6th. The stock was sold at an average price of $112.08, for a total transaction of $15,039,230.64. Following the sale, the director now directly owns 253,510 shares of the company's stock, valued at $28,413,400.80. This represents a 34.61% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Jon Kessler also recently made the following trade(s):

• On Friday, June 6th, Jon Kessler sold 97,767 shares of HealthEquity stock. The shares were sold at an average price of $112.05, for a total value of $10,954,792.35.

HealthEquity Trading Down 0.9%

HQY traded down $0.97 during midday trading on Thursday, hitting $103.59. 417,263 shares of the company were exchanged, compared to its average volume of 833,525. The firm's 50 day moving average price is $92.93 and its 200-day moving average price is $97.88. HealthEquity, Inc. has a 1-year low of $65.01 and a 1-year high of $116.65. The firm has a market capitalization of $8.96 billion, a P/E ratio of 95.04, a P/E/G ratio of 1.60 and a beta of 0.49. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51.

HealthEquity (NASDAQ:HQY - Get Free Report) last issued its quarterly earnings data on Tuesday, June 3rd. The company reported $0.97 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.81 by $0.16. HealthEquity had a return on equity of 9.70% and a net margin of 8.41%. The company had revenue of $330.80 million during the quarter, compared to the consensus estimate of $322.25 million. During the same period last year, the company earned $0.80 earnings per share. As a group, equities analysts forecast that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

Institutional Investors Weigh In On HealthEquity

A number of institutional investors have recently modified their holdings of HQY. Inspire Investing LLC raised its stake in HealthEquity by 8.6% during the first quarter. Inspire Investing LLC now owns 7,529 shares of the company's stock worth $665,000 after buying an additional 597 shares during the last quarter. Hodges Capital Management Inc. bought a new position in shares of HealthEquity in the 1st quarter worth about $1,988,000. Strs Ohio acquired a new position in shares of HealthEquity in the 1st quarter valued at about $999,000. Mattson Financial Services LLC lifted its stake in shares of HealthEquity by 15.5% in the 1st quarter. Mattson Financial Services LLC now owns 1,988 shares of the company's stock valued at $176,000 after purchasing an additional 267 shares during the period. Finally, Belpointe Asset Management LLC bought a new stake in shares of HealthEquity during the 1st quarter valued at about $756,000. 99.55% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages recently weighed in on HQY. Wall Street Zen upgraded HealthEquity from a "hold" rating to a "buy" rating in a research report on Friday, June 6th. KeyCorp dropped their target price on shares of HealthEquity from $110.00 to $100.00 and set an "overweight" rating for the company in a report on Wednesday, April 16th. JMP Securities lifted their price target on shares of HealthEquity from $110.00 to $117.00 and gave the company a "market outperform" rating in a report on Wednesday, June 4th. Raymond James raised shares of HealthEquity from an "outperform" rating to a "strong-buy" rating and decreased their target price for the stock from $120.00 to $115.00 in a research note on Tuesday, March 25th. Finally, Wells Fargo & Company increased their price target on HealthEquity from $110.00 to $125.00 and gave the company an "overweight" rating in a research note on Wednesday, February 26th. One research analyst has rated the stock with a hold rating, ten have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, HealthEquity has an average rating of "Buy" and a consensus price target of $118.09.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.